Home › Triple-Negative Breast Cancer › Missouri › Springfield
Triple-Negative Breast Cancer clinical trials in Springfield, MO
3 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Springfield (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
RecruitingObservational study
- Oncology Hematology Associates, Springfield
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
RecruitingObservational study
- Mercy Hospital - SPG, Springfield
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
RecruitingPhase 3
- Cox Medical Center, Springfield
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Springfield
- Colorectal Cancer11 studies
- Cancer (all types)10 studies
- Breast Cancer10 studies
- Non-Small Cell Lung Cancer10 studies
- Obesity7 studies
- Overweight7 studies
- Melanoma6 studies
- Lung Cancer6 studies
- Metastatic Cancer6 studies
- Ovarian Cancer5 studies
- Colon Cancer5 studies
- Bladder Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.